STOCK TITAN

Zimmer Biomet (NYSE: ZBH) awards 10,168 RSUs to President, APAC

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Desai Chintan reported acquisition or exercise transactions in this Form 4 filing.

Zimmer Biomet Holdings, Inc. reported an equity award to executive Chintan Desai, President, APAC. On August 3, 2026, he received 10,168 restricted stock units (RSUs), each representing a contingent right to one share of common stock. One-third of the RSUs vest on each of August 3, 2027, 2028 and 2029, and following this award he holds 10,168 RSUs of this type.

Positive

  • None.

Negative

  • None.
Insider Desai Chintan
Role President, APAC
Type Security Shares Price Value
Grant/Award Restricted Stock Units F1, F2 10,168 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 10,168 shares (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
  2. F2. One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.
RSUs granted 10,168 units Restricted stock units awarded to Chintan Desai on 2026-08-03
Underlying common shares 10,168 shares Each RSU represents a contingent right to one share of common stock
RSUs following transaction 10,168 units Total restricted stock units held directly after the award
Annual vesting fraction 1/3 of grant One-third of RSUs vest on each of August 3, 2027, 2028 and 2029
Restricted Stock Units financial
"Security title is listed as Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents a contingent right to receive one share"
vest financial
"One-third of the RSUs shall vest on each of August 3"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did ZBH report for executive Chintan Desai?

Zimmer Biomet reported a grant of 10,168 restricted stock units (RSUs) to Chintan Desai, President, APAC, on August 3, 2026. The Form 4 classifies this as a grant, award, or other acquisition rather than an open-market trade, with all units tied to common stock.

How many RSUs were granted to Chintan Desai at ZBH and what do they represent?

Chintan Desai received 10,168 restricted stock units from Zimmer Biomet. According to the filing, each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock, aligning the executive’s interests with long-term shareholder value.

What is the vesting schedule for Chintan Desai’s ZBH restricted stock units?

The 10,168 RSUs vest in three equal installments. One-third of the RSUs vests on each of August 3, 2027, August 3, 2028, and August 3, 2029. This three-year vesting structure spreads the potential share delivery over multiple future dates.

Is the reported ZBH transaction a market purchase or sale of shares?

No, the transaction is reported as a grant, award, or other acquisition of restricted stock units, coded “A” on Form 4. It does not reflect an open-market purchase or sale of Zimmer Biomet common stock by the executive on that date.

How many RSUs does Chintan Desai hold after this Zimmer Biomet award?

After the August 3, 2026 award, the Form 4 shows Chintan Desai directly holding 10,168 restricted stock units of this type. This figure reflects his total RSU position following the reported transaction, as disclosed in the post-transaction holdings column.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Desai Chintan

(Last)(First)(Middle)
345 EAST MAIN STREET

(Street)
WARSAW INDIANA 46580

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President, APAC
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)08/03/2026A10,168 (2) (2)Common Stock10,168$010,168D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.
2. One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.
/s/ Matthew R. St. Louis, Attorney-in-Fact for Chintan Desai (power of attorney previously filed)08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)